BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26221260)

  • 21. Identification of important invasion and proliferation related genes in adrenocortical carcinoma.
    Alshabi AM; Vastrad B; Shaikh IA; Vastrad C
    Med Oncol; 2019 Jul; 36(9):73. PubMed ID: 31321566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
    Hu S; Liao Y; Chen L
    Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mining Featured Biomarkers Linked with Epithelial Ovarian CancerBased on Bioinformatics.
    Alur VC; Raju V; Vastrad B; Vastrad C
    Diagnostics (Basel); 2019 Apr; 9(2):. PubMed ID: 30970615
    [No Abstract]   [Full Text] [Related]  

  • 24. Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach.
    Fang E; Zhang X; Wang Q; Wang D
    Cancer Biomark; 2017 Dec; 20(4):553-561. PubMed ID: 28800317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Revealing the underlying mechanism of diabetic nephropathy viewed by microarray analysis.
    Qu W; Han C; Li M; Zhang J; Li L
    Exp Clin Endocrinol Diabetes; 2015 Jun; 123(6):353-9. PubMed ID: 25918880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The screening of pivotal gene expression signatures and biomarkers in renal carcinoma.
    Ruan H; Li S; Tong J; Cao Q; Song Z; Wang K; Huang Y; Bao L; Chen X; Yang H; Chen K; Zhang X
    J Cancer; 2019; 10(25):6384-6394. PubMed ID: 31772671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of key differentially expressed mRNAs and microRNAs in non-small cell lung cancer using bioinformatics analysis.
    Wang W; Wang S; Pan L
    Exp Ther Med; 2020 Oct; 20(4):3720-3732. PubMed ID: 32855723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
    Li T; Gao X; Han L; Yu J; Li H
    World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of key genes and microRNAs involved in kidney Wilms tumor by integrated bioinformatics analysis.
    Zhang L; Gao X; Zhou X; Qin Z; Wang Y; Li R; Tang M; Wang W; Zhang W
    Exp Ther Med; 2019 Oct; 18(4):2554-2564. PubMed ID: 31555364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioinformatics analysis of gene expression profiles of esophageal squamous cell carcinoma.
    He Y; Liu J; Zhao Z; Zhao H
    Dis Esophagus; 2017 May; 30(5):1-8. PubMed ID: 28375447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring the Molecular Mechanism of the Drug-Treated Breast Cancer Based on Gene Expression Microarray.
    Alshabi AM; ; Shaikh IA; Vastrad C
    Biomolecules; 2019 Jul; 9(7):. PubMed ID: 31311202
    [No Abstract]   [Full Text] [Related]  

  • 32. Identification of key target genes and biological pathways in multiple sclerosis brains using microarray data obtained from the Gene Expression Omnibus database.
    Zheng W; Chen Y; Chen H; Xiao W; Liang Y; Wang N; Jiang X; Wen S
    Neurol Res; 2018 Oct; 40(10):883-891. PubMed ID: 30074468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
    Li Y; Li L
    J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of potential crucial genes associated with carcinogenesis of clear cell renal cell carcinoma.
    Song E; Song W; Ren M; Xing L; Ni W; Li Y; Gong M; Zhao M; Ma X; Zhang X; An R
    J Cell Biochem; 2018 Jul; 119(7):5163-5174. PubMed ID: 29227586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of differentially-expressed microRNAs and genes in cervical cancer using an integrated bioinformatics analysis.
    Xu Z; Zhou Y; Shi F; Cao Y; Dinh TLA; Wan J; Zhao M
    Oncol Lett; 2017 Apr; 13(4):2784-2790. PubMed ID: 28454467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of biological targets of therapeutic intervention for diabetic nephropathy with bioinformatics approach.
    Wu T; Li Q; Wu T; Liu HY
    Exp Clin Endocrinol Diabetes; 2014 Nov; 122(10):587-91. PubMed ID: 25003364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene expression profiling analysis of the role of miR-22 in clear cell ovarian cancer.
    Zhen YB; Guo XL; Xu B; Zhao HW; Xu CJ
    Neoplasma; 2016; 63(6):856-864. PubMed ID: 27565323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional Regulatory Network Analysis for Gastric Cancer Based on mRNA Microarray.
    Wang Y
    Pathol Oncol Res; 2017 Oct; 23(4):785-791. PubMed ID: 28078605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of potential therapeutic target genes and mechanisms in non-small-cell lung carcinoma in non-smoking women based on bioinformatics analysis.
    Zhou W; Yin M; Cui H; Wang N; Zhao LL; Yuan LZ; Yang XP; Ding XM; Men FZ; Ma X; Na JR
    Eur Rev Med Pharmacol Sci; 2015 Sep; 19(18):3375-84. PubMed ID: 26439031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of key genes and micro-RNA-mRNA regulatory networks in women with ulcerative interstitial cystitis/pain bladder syndrome.
    Liu S; Feng S; Luo D
    Int Urogynecol J; 2019 Sep; 30(9):1487-1495. PubMed ID: 30456462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.